- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
- Earnings
Q3 2020 Novo Nordisk A/S Earnings Call (London-Based Investors) Transcript
Hello, and welcome to the Q3 2020 Novo Nordisk A/S Earnings Presentation. (Operator Instructions) Today I am pleased to present Karsten Munk Knudsen. Please go ahead with your meeting.
/- -
Thank you. And welcome to the Novo Nordisk third quarter results meeting. It's a pleasure to host this meeting, and a big thanks to Richard Vosser and JPMorgan for helping setting up this meeting. So for the meeting today, we have an update on our strategic aspirations, followed by COVID-19, commercial execution, innovation and therapeutic focus and financials. So organized in line with our strategic aspiration framework. We have planned it in a way. So the presentations will be followed by a Q&A session in the end.
As you all know, then statements around the future inherently are covered by a certain level of uncertainty. And hence, we remind you about this circumstance.
Moving on to our strategic aspirations. Then more
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |